Transactions

St. Louis Clinical Trials recapitalized by DFW Capital Partners

Apr. 2014

Our Client: SLCT is a leading clinical pharmacology and research services company focusing on psychiatric indications

Our Role: Edgemont Capital Partners acted as exclusive financial advisor to St. Louis Clinical Trials in its recapitalization and merger to form Evolution Research Group sponsored by DFW Capital

Location: St. Louis, MO

Sector: Pharmaceutical Services

Connect with Lead Banker

st. louis clinical trials logo

recapitalized by

dfw capital partners logo
Get In Touch